Treating high-risk people with a rheumatoid arthritis drug could help delay the condition's onset by up to 4 years, new research suggests.

More than 18 million people worldwide suffer from rheumatoid arthritis, including nearly 1.5 million Americans.

Rheumatoid arthritis (RA) is a common autoimmune disease where the body's immune system mistakenly attacks the lining of its own joints, causing chronic pain, swelling, and stiffness. While there have ...

Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes inflammation throughout the body and most often affects the joints, leading to pain, stiffness, swelling, and reduced mobility.

It's well established that gum disease and rheumatoid arthritis (RA) are strongly linked. But what wasn't known, until a ...

Patients with rheumatoid arthritis (RA) and RA-interstitial lung disease are at an increased risk of lung cancer, according to the results of a retrospective, matched cohort study. "Prior studies have ...

A vast majority of patients with rheumatoid arthritis (RA) experienced at least one objectively-measured sleep disorder, and some of those disorders were significantly associated with greater clinical ...

Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease for several years, with ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost management strategies.

New findings reveal that rheumatoid arthritis (RA) disease activity significantly affects the severity of interstitial lung disease (ILD), both radiologically and physiologically, in patients with RA ...

Please provide your email address to receive an email when new articles are posted on . RA-ILD was associated with an increased risk for infection vs. RA without lung disease. RA-associated ...